Rajesh Gottumukkala

Private equity investor in Chicago

Invests in AI

Rajesh Gottumukkala's investor profile lists AI alongside EdTech and Healthcare & Biotech, at Series B and late-stage venture. The record holds 4 deals, among them Spiro.AI, Next Step Test Prep and LGM Pharma.

Email Investor

Email Investor

Credits to line up before a Series B round

Rajesh Gottumukkala backs companies at Series B and late-stage venture. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • Spiro.AI
  • Next Step Test Prep
  • LGM Pharma
  • Blueprint Test Preparation

Investment focus

Backs startups in
Artificial Intelligence, EdTech, Healthcare & Biotech
Rounds
Series B, Late-stage venture
Profile
Private equity investor
Deals on record
4
Based in
Chicago, United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Rajesh Gottumukkala invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Rajesh Gottumukkala's investor profile, together with EdTech and Healthcare & Biotech. The stages on record are Series B and late-stage venture.
Which companies has Rajesh Gottumukkala backed?
The record lists 4 deals, including Spiro.AI, Next Step Test Prep, LGM Pharma and Blueprint Test Preparation. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Rajesh Gottumukkala?
For a company raising a Series B round, AI Perks lists credits such as Attio (up to $5,000), HubSpot via DigitalOcean (up to $8,000), Yext (up to $35,000) and Upwork (up to $20,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor